Weekly reads: upbeat early Aspen stem cells for Parkinson’s trial data, Capricor, hematopoietic editing

Autologous iPSC-derived neurons, stem cells for Parkinson's

I recently wrote about the upbeat early reports from two allogeneic trials of stem cells for Parkinson’s. Now there’s additional encouraging early news on this front but using patients’ own cells. This is one of the most promising areas of regenerative medicine. Stem cells for Parkinson’s: Aspen Neuroscience upbeat early data California biotech Aspen Neuroscience

Weekly reads: upbeat early Aspen stem cells for Parkinson’s trial data, Capricor, hematopoietic editing Read More »

Upcoming new Florida stem cell law risks far more consumer harm in that state

Florida stem cell law, Mari Mitrani

A risky new Florida stem cell law is likely to come into effect in a matter of weeks as the state senate and house both unanimously passed versions of their respective stem cell bills. I imagine that Florida Governor Ron DeSantis will sign it. It will be effective July 1, opening the door to unproven

Upcoming new Florida stem cell law risks far more consumer harm in that state Read More »

Weekly reads: stem cells everywhere, MSCs for MS?, nanostickers, Makary update

MSC cruises, MSCs for MS

It was another crazy week for me with tons of grant work, but news  and research in the regenerative medicine world keep on popping up including a paper on MSCs for MS. I’ve realized that even when I’m trying to take a short break, I often see science and signs of stem cells popping up

Weekly reads: stem cells everywhere, MSCs for MS?, nanostickers, Makary update Read More »

FDA critic Vinay Prasad to run CBER: more politics than experience?

Vinay Prasad, FDA Vinay Prasad

The FDA has a new CBER Director Dr. Vinay Prasad. CBER is the FDA’s biologics branch that handles things like cell therapies and vaccines. The branch has been in near-constant upheaval this year. For a time, Scott Steele was acting CBER Director. It wasn’t clear if he was there in a temporary capacity or would

FDA critic Vinay Prasad to run CBER: more politics than experience? Read More »

Weekly reads: pericytes, Nature says don’t rush stem cell OKs, microglia for Alzheimer’s, MYCN

Pericytes

What are pericytes? What about brain pericytes? How are they different than brain parasites? Pericytes on the brain Someone once asked me my favorite type of cell. As a cell biologist, I easily can’t pick just one. It’s like asking a parent to pick their favorite child. However, I will say that pericytes and microglia

Weekly reads: pericytes, Nature says don’t rush stem cell OKs, microglia for Alzheimer’s, MYCN Read More »

Google’s Gemini AI schools Google Search on its risky stem cell results

Stem cells for autism

Readers of The Niche will probably recall that I’ve been critical of Google Search on stem cells. The search engine giant does unintended promotion of unproven stem cells and the clinics that sell them, like a Ukrainian clinic whose website Google still seems to view as the world’s expert on stem cells for autism, which,

Google’s Gemini AI schools Google Search on its risky stem cell results Read More »

Weekly reads: stem cell marathon, Ray Therapeutics, stem cells making you fat?

marathon, stem cell

Stem cells can be serious business, but sometimes stories come along that are just fun like a lady running a marathon dressed as a stem cell. How cool is this: “Louise Cato from Somerset is doing the run to raise money for the charity Anthony Nolan, after her dad had a bone marrow transplant over

Weekly reads: stem cell marathon, Ray Therapeutics, stem cells making you fat? Read More »

Why the FDA & CBER leadership purge will be so bad for biotech

FDA, FDA Trump

The Trump Administration just quickly gutted the FDA including key leadership. What is going to be the impact of this sudden purge? Former Commissioner Robert Califf recently said it is the end of the FDA as we’ve known it. Those are dramatic words, but they seem on the money to me. As a biomedical scientist

Why the FDA & CBER leadership purge will be so bad for biotech Read More »

Weekly stem cell reads: tomato stem cells, FDA blacklist, CALEC, odd RFK Jr. summit

stem cell, tomato stem cells

Some of you may know that gardening is one of my hobbies and I see it as akin to science, even like growing stem cell cultures. Tomatoes are my favorite thing to grow. About ten years ago I started sprouting my own tomato plants from seed. It’s surprisingly easy with grow lights. This way you

Weekly stem cell reads: tomato stem cells, FDA blacklist, CALEC, odd RFK Jr. summit Read More »

Subscribe to Our Newsletter

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.